Drawing on the film Wonder, this article examines how a narrative of community acceptance offers sustaining relationships for people with unusual facial appearance.
AMA J Ethics. 2019;21(11):E1003-1008. doi:
10.1001/amajethics.2019.1003.
Katelyn G. Bennett, MD and Christian J. Vercler, MD, MA
Plastic surgeons who use patient images for online advertising should ensure informed consent and not exploit the patient-physician relationship for gain.
AMA J Ethics. 2018;20(4):328-335. doi:
10.1001/journalofethics.2018.20.4.ecas1-1804.
Advertising a plastic surgery practice on social media can be ethically fraught, and deceptive online marketing techniques can lead to patients feeling betrayed.
AMA J Ethics. 2018;20(4):372-378. doi:
10.1001/journalofethics.2018.20.4.msoc2-1804.
Plastic surgeons’ use of patient images on social media should conform to the American Society of Plastic Surgeons’ advertising and image use guidelines.
AMA J Ethics. 2018;20(4):379-383. doi:
10.1001/journalofethics.2018.20.4.msoc3-1804.
Devan Stahl, PhD, MDiv and Christian J. Vercler, MD, MA
Social and cultural influences significantly contribute to our conceptions of healthy and pathological anatomy, and surgeons play critical roles in how these influences are expressed in clinical settings and social media.
AMA J Ethics. 2018;20(4):384-391. doi:
10.1001/journalofethics.2018.20.4.msoc4-1804.
Joel A. DeLisa, MD, MS and Jacob Jay Lindenthal, PhD, DrPH
Research on experiences of practicing physicians who have disabilities could help medical schools counsel applicants and increase enrollment among students with disabilities. This can ultimately improve care for patients with disabilities.
AMA J Ethics. 2016;18(10):1003-1009. doi:
10.1001/journalofethics.2016.18.10.stas1-1610.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"